Tobacco and Public Health - TCSC Indonesia

638
GENES, NICOTINE ADDICTION, SMOKING BEHAVIOUR, AND CANCER
References
Bergen, A. W., Korczak, J. F., Weissbecker, K. A., and Goldstein, A. M. (1999). A genome-wide search
for loci contributing to smoking and alcoholism. Genet Epidemiol Suppl, 17, S55–S60.
Breslau, N. (1995). Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet, 25,
95–101.
Crabbe, J. C. (2002). Genetic contributions to addiction. Annu Rev Psychol, 53, 435–62.
David, S. P., Johnstone, E., Griffiths, S. E., Murphy, M., Yudkin, P., and Walton, R. (2002). No
association between functional Catechol O-Methyl Transferase Polymorphism (COMT A1947G)
and smoking initiation, maintenance or cessation. Pharmacogenetics, 12, 265–8.
David, S. P., Niaura, R. S., Papandonatos, G. D., Shadel, W. G., Burkholdes, G. J., Britt, D. M., Day, A.,
Stumpff, J., Hutdrinson, K., Murphy, M., Johnstone, E., Griffiths, S.-E., and Walton, R. T.
(2004 inpress). Does the DRD2-Taq1A polymorphism influence treatment response to bupropion
hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine and Tobacco Research.
Doll, R. and Peto, R. (1976). Mortality in relation to smoking: 20 years’ observations on male British
doctors. Br Med J, 2(6051), 1525–36.
Duell, E. J., Millikan, R. C., et al. (2001). Polymorphisms in the DNA repair gene XRCCI and breast
cancer. Cancer Epidemiol Biomarkers Prev, 11, 23–7.
Duggirala, R., Almasy, L., and Blangero, J. (1999). Smoking behaviour is under the influence of a
major quantitative trait locus on human chromosome 5q. Genet Epidemiol Suppl, 17, S139–44.
Gilbert, D. G. and Gilbert, B. O. (1995). Personality, psychopathology, and nicotine response as mediators
of the genetics of smoking. Behav Genet, 25, 133–47.
Hall,W., Madden, P., and Lysnskey, M. (2002). The genetics of tobacco use: Methods, findings and
policy implications. Tobacco Control, 11(2), 119–124.
Heath, A. C., Madden, P. A. F., Slutske, W. S., and Martin, N. G. (1995). Personality and the
inheritance of smoking behavior: A genetic perspective. Behav Genet, 25, 103–17.
Johnstone, E., Munafò, M., Neville, M., Griffiths, S., Murphy, M., and Walton, R. (2002).
Pharmacogenomics of Tobacco Addiction. Chapter 22 In: Pharmacogenomics: The search for
individualised therapeutics (ed. J. Licinio, and M-L. Wong), pp. 443–60. Wiley Verlag,
Weinheim Germany.
Johnstone, E., Clark, T., Griffiths, S. E., Murphy, M. F. G., and Walton, R. T. (2002) Polymorphisms in
dopamine metabolic enzymes and tobacco consumption in smokers—seeking confirmation of
the association in a follow-up study. Pharmacogenetics, 12(7), 585–7.
Johnstone, E. C., Yudkin, P. L., Hey, K., Roberts, S. J., Welch, S. J., Murphy, M. F. G., Griffiths, S. E.,
and Walton, R. T. (2004 in press). Genetic variation in dopaminergic pathways and short term
effectiveness of the nicotine patch. Pharmacogenetics.
Leonard, B. E. (1999). Neuropharmacology of antidepressants that modify central noradrenergic and
serotonergic function: A short review. Hum Psychopharmacol Clin Exp, 14, 75–81.
Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Hawk, L. H. Jr, Pinto, A., Kucharski, S.,
Krishnan, S., Niaura, R., and Epstein, L. H. (2002). Effects of dopamine transporter and receptor
polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol, Sept 22(5),
541–8.
Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Hawk, L. H. Jr, Pinto, A., Krishnan, S.,
Niaura, R., and Epstein, L. H. (2002). Pharmacogenetic investigation of smoking cessation
treatment. Pharmacogenetics. Nov 12(8), 627–34.
Li, M. D., Cheng, R., Ma, J. S., and Swan, G. E. (2003). A meta-analysis of estimated genetic and
environmental effects on smoking behavior in male and female adult twins. Addiction, 98, 23–32.